Case Report: Successful Treatment with Daratumumab for Pure Red Cell Aplasia in a Patient with Mixed Lymphoid Chimerism after ABO-mismatched Stem Cell Transplant for Sickle Cell Disease.
FRONTIERS IN IMMUNOLOGY（2023）
Key words
sickle cell disease,hematopoietic (stem) cell transplantation (HCST),pure red cell aplasia (PRCA),mixed chimerism,daratumumab (DARA)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined